Back to Search Start Over

Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial

Authors :
Staven S Raman
Ida Sonni
Ely Felker
Anthony Sisk
Wesley R Armstrong
Tristan Grogan
Jeremie Calais
Teeravut Tubtawee
Robert E. Reiter
Andrew T. Lenis
David Elashoff
Shadfar Bahri
Johannes Czernin
Matthias Eiber
Martin Allen-Auerbach
Voraparee Suvannarerg
Source :
Journal of Nuclear Medicine. 63:847-854
Publication Year :
2021
Publisher :
Society of Nuclear Medicine, 2021.

Abstract

The role of prostate-specific membrane antigen (PSMA)-targeted PET in comparison to mpMRI in the evaluation of intraprostatic cancer foci is not well defined. The aim of our study was to compare the diagnostic performances of PSMA PET/CT, mpMRI and PSMA PET/CT+mpMRI using 3 independent blinded readers for each modality and with histopathology as gold standard in the detection, intra-prostatic localization and local extension of primary prostate cancer. Methods: Patients with intermediate- or high-risk prostate cancer who underwent a PSMA PET/CT as part of the prospective trial (NCT03368547) and a mpMRI prior to radical prostatectomy were included. Each imaging modality was interpreted by 3 blinded independent readers unaware of the other modality result. Central majority rule was applied (2:1). Whole-mount pathology was used as the gold-standard. Imaging scans and whole-mount pathology were interpreted using the same standardized approach on a segment- and lesion-level. A “neighboring” approach was used to define imaging/pathology correlation for the detection of individual prostate cancer foci. Accuracy in determining the location, extraprostatic extension (EPE) and seminal vesicle invasion (SVI) of prostate cancer foci was assessed using receiver operating characteristic (ROC) analysis. Inter-reader agreement was calculated using inter-class coefficient (ICC) analysis. Results: The final analysis included 74 patients (14/74 ( 19%) intermediate risk and 60/74 (81%) high risk). Cancer detection rate (lesion-based analysis) was 85%, 83% and 87 for PSMA PET/CT, mpMRI and PSMA PET/CT+mpMRI, respectively. ΔAUC between PSMA PET/CT+mpMRI and the two imaging modalities alone for delineation of tumor localization (segment-based analysis) was statistically significant (p

Details

ISSN :
2159662X and 01615505
Volume :
63
Database :
OpenAIRE
Journal :
Journal of Nuclear Medicine
Accession number :
edsair.doi...........6a334e38294e8b6b5212e57516cf43bd
Full Text :
https://doi.org/10.2967/jnumed.121.262398